1. Home
  2. BREA vs VRAX Comparison

BREA vs VRAX Comparison

Compare BREA & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BREA
  • VRAX
  • Stock Information
  • Founded
  • BREA 2022
  • VRAX 2013
  • Country
  • BREA Ireland
  • VRAX United Kingdom
  • Employees
  • BREA N/A
  • VRAX N/A
  • Industry
  • BREA Services-Misc. Amusement & Recreation
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • BREA Consumer Discretionary
  • VRAX Health Care
  • Exchange
  • BREA Nasdaq
  • VRAX Nasdaq
  • Market Cap
  • BREA 8.7M
  • VRAX 7.3M
  • IPO Year
  • BREA 2023
  • VRAX 2022
  • Fundamental
  • Price
  • BREA $0.63
  • VRAX $1.90
  • Analyst Decision
  • BREA
  • VRAX
  • Analyst Count
  • BREA 0
  • VRAX 0
  • Target Price
  • BREA N/A
  • VRAX N/A
  • AVG Volume (30 Days)
  • BREA 40.6K
  • VRAX 293.5K
  • Earning Date
  • BREA 01-03-2025
  • VRAX 02-05-2025
  • Dividend Yield
  • BREA N/A
  • VRAX N/A
  • EPS Growth
  • BREA N/A
  • VRAX N/A
  • EPS
  • BREA N/A
  • VRAX N/A
  • Revenue
  • BREA $2,872,101.00
  • VRAX $84,872.00
  • Revenue This Year
  • BREA N/A
  • VRAX $5,169.18
  • Revenue Next Year
  • BREA N/A
  • VRAX $66.97
  • P/E Ratio
  • BREA N/A
  • VRAX N/A
  • Revenue Growth
  • BREA 2338.69
  • VRAX 7.03
  • 52 Week Low
  • BREA $0.50
  • VRAX $0.60
  • 52 Week High
  • BREA $2.44
  • VRAX $9.00
  • Technical
  • Relative Strength Index (RSI)
  • BREA 38.35
  • VRAX 49.13
  • Support Level
  • BREA $0.60
  • VRAX $1.58
  • Resistance Level
  • BREA $0.67
  • VRAX $2.10
  • Average True Range (ATR)
  • BREA 0.04
  • VRAX 0.25
  • MACD
  • BREA -0.01
  • VRAX 0.01
  • Stochastic Oscillator
  • BREA 13.91
  • VRAX 47.88

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Share on Social Networks: